Join to View Full Profile
1215 Lee St2nd FloorCharlottesville, VA 22903
Phone+1 434-924-5219
Dr. Kaski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical Education/MercyResidency, Internal Medicine, 2021 - 2024- UPMC Medical EducationResidency, Internal Medicine, 2021 - 2024
West Virginia University School of MedicineClass of 2022
Certifications & Licensure
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 12 citationsPreclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.Yan Zhou, Kevin B. Freeman, Vincent Setola, Danni Cao, Shane W Kaski
Handbook of Experimental Pharmacology. 2021-04-09 - 2 citationsSublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients.Shane W Kaski, Patrick Marshalek, Jeremy Herschler, Sijin Wen, Wanhong Zheng
Journal of Clinical Medicine. 2021-03-02 - 37 citationsPreclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.Shane W Kaski, Allison N White, Joshua D Gross, Kristen R Trexler, Kim Wix
The Journal of Pharmacology and Experimental Therapeutics. 2019-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
